Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB06213
http://purl.obolibrary.org/obo/dinto_DB06213
|
|---|---|
| Preferred Name | regadenoson |
| Synonyms |
1-{6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-2-yl}-N-methyl-1H-pyrazole-4-carboxamide
C15H18N8O5
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | regadenoson
|
|---|---|
| label | regadenoson
|
| DBSynonym | cvt-3146
|
| ATCCode | C01EB21
|
| Definition | Regadenoson is an A2A adenosine receptor agonist that causes coronary vasodilation and used for myocardial perfusion imagining. Manufactured by Astellas and FDA approved April 10, 2008.
|
| has pharmacological target | |
| activates | |
| type | |
| InChIKey | InChIKey=LZPZPHGJDAGEJZ-AKAIJSEGSA-N
|
| Synonym | 1-{6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-2-yl}-N-methyl-1H-pyrazole-4-carboxamide
C15H18N8O5
|
| xref |
RxList:http://www.rxlist.com/cgi/generic/lexiscan.htm
PDRhealth:http://www.pdrhealth.com/drugs/lexiscan
PubChem Substance:47207372
National Drug Code Directory:0469-6501-89
BindingDB:50119132
ChemSpider:189859
PubChem Compound:219024
Drugs.com:http://www.drugs.com/ppa/regadenoson.html
Wikipedia:http://en.wikipedia.org/wiki/Regadenoson
See more
See less
|
| CASRN | 313348-27-5
|
| prefixIRI | obo2:dinto_DB06213
|
| SMILES | CNC(=O)C1=CN(N=C1)C1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(N)=N1
|
| may interact with | |
| InChI | InChI=1S/C15H18N8O5/c1-17-13(27)6-2-19-23(3-6)15-20-11(16)8-12(21-15)22(5-18-8)14-10(26)9(25)7(4-24)28-14/h2-3,5,7,9-10,14,24-26H,4H2,1H3,(H,17,27)(H2,16,20,21)/t7-,9-,10-,14-/m1/s1
|
| DBBrand | lexiscan
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |